Open-Heart Medicine and Innovative Integrative Therapies for Complex Chronic Diseases

1. Eliaz I , Raz A . Pleiotropic effects of modified citrus pectin. Nutrients, 2019; 11:2619.

2. Dong R , Zhang M , Hu Q , et al. Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy. Int J Mol Med, 2018; 41:599–614.

3. Bouffette S , Botez I , De Ceuninck F . Targeting galectin-3 in inflammatory and fibrotic diseases. Trends Pharmacol Sci, 2023; 44:519–531.

4. Sun H , Peng J , Cai S , et al. A translational study of Galectin-3 as an early biomarker and potential therapeutic target for ischemic-reperfusion induced acute kidney injury. J Crit Care, 2021; 65:192–199.

5. Sun H , Jiang H , Eliaz A , et al. Galectin-3 in septic acute kidney injury: A translational study. Crit Care, 2021; 25:109.

6. Eliaz I . The survival paradox: reversing the hidden cause of aging and chronic disease. 2021; Lioncrest Publishing.

7. Eliaz I , Weil E . Intravenous Honokiol in drug-resistant cancer: Two case reports. Integr Cancer Ther, 2020; 19:1534735420922615.